Skip to main content
Not investment advice. Educational platform. See Disclaimer.
AMEX: STXS

Stereotaxis, Inc.

Healthcare | Medical - Instruments & Supplies

No licensed closing price on file for STXS. This page shows the company’s SEC filings and filed figures, without a price or any ratio that depends on one.

EPS (TTM)$-0.24

Stereotaxis, Inc. (AMEX: STXS) is a medical instruments and supplies company. Figures from SEC EDGAR; updated 2026-10-20 06:00 UTC.

What Stereotaxis, Inc. does

Stereotaxis, Inc. develops and manufactures medical devices for interventional procedures, operating under various trademark names including GenesisX RMN, Niobe, Navigant, and other robotic and imaging systems used in catheter-based interventions. The company produces both capital equipment platforms and disposable interventional devices designed to enable physicians to perform cardiac and other minimally invasive procedures.

Summarized from Stereotaxis, Inc.’s SEC filings · AI-generated analysis. Not investment advice. May contain errors. · Read the filing ↗

Pre-revenue, development-stage company: standard profitability ratios (P/E, EV/EBITDA, ROE) do not apply yet because there are no earnings. Watch cash, cash runway, net loss, R&D spend and share dilution instead.

Key facts

Valuation
EPS (TTM)$-0.24

Revenue, margins & earnings

FY2021: net loss $11M on revenue $35M$35MFY2021FY2022: net loss $18M on revenue $28M$28MFY2022FY2023: net loss $21M on revenue $27M$27MFY2023FY2024: net loss $24M on revenue $27M$27MFY2024FY2025: net loss $22M on revenue $32M$32MFY2025
  • Net income
  • Taxes & interest
  • Operating expenses
  • Cost of revenue
  • Net loss year
Annual revenue; bands show net, operating, gross margins · Open in Platform →

SEC Filings

SEC EDGAR ↗
Recent Insider Activity
Source: SEC EDGAR · Filed 2026-07-01
Most recent filed transactions — July 2026:
  • 2026-07-01DirectorAward43,103—
  • 2026-07-01DirectorAward43,103—
  • 2026-07-01DirectorAward43,103—
Sign in to see all transactions →
Recent 8-K Events (parsed from SEC filings)All events →
Source: SEC EDGAR 8-K filings · Interpretation: Oxford Ledge parser · Confidence-filtered ≥ 0.50

Company news

View all →

Questions this page answers

What does Stereotaxis, Inc. do?

Stereotaxis, Inc. is a medical instruments and supplies company, listed on AMEX as STXS.

When did STXS last file with the SEC?

Stereotaxis, Inc.'s most recent SEC filing on record is a SCHEDULE 13G filed 2026-08-19. All filings link to their SEC EDGAR originals above.

Where does this data come from?

SEC EDGAR filings, with the company profile (sector, industry, exchange) from public data providers, fetched 2026-10-20 06:00 UTC. This page is also available as JSON at /api/data?ticker=STXS and is emitted with FAQPage structured data for machine reading.

For you

Charts, 10-year financials, peer comparison, screening and portfolio tracking for STXS and 5,000+ tickers.

Create a free account — keep STXS
For your agent
GET /api/data?ticker=STXS

This page as JSON via rel="alternate" · REST API docs · MCP server (60 tools) · llms.txt